Synthesis and evaluation of condensed magnetic nanocrystal clusters with in vivo multispectral optoacoustic tomography for tumour targeting

Biomaterials

Volumn 91, Issue , 2016, Pages 128-139

  Sarigiannis, Yiannis ^a,d   Kolokithas Ntoukas, Argiris ^a   Beziere, Nicolas ^b   Zbořil, Radek ^c   Papadimitriou, Evangelia ^a   Avgoustakis, Konstantinos ^a   Lamprou, Margarita ^a   Medrikova, Zdenka ^c   Rousalis, Elias ^a   Ntziachristos, Vasilis ^b   Bakandritsos, Aristides ^a,c  

^a UNIVERSITY OF PATRAS   (Greece)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c PALACKÝ UNIVERSITY   (Czech Republic)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Hybrid colloids; Hyperthermia; Magnetic targeting; Nanocrystal clusters; Optoacoustic imaging; Theranostics

Indexed keywords

BIOCOMPATIBILITY; CELLULOSE DERIVATIVES; COLLOIDS; COST EFFECTIVENESS; DRUG DELIVERY; IRON OXIDES; MAGNETIC RESONANCE IMAGING; MEDICAL NANOTECHNOLOGY; NANOCRYSTALS; PETROLEUM RESERVOIR EVALUATION; PHOTOACOUSTIC EFFECT; THERANOSTICS; TOMOGRAPHY;

HYBRID COLLOIDS; HYPERTHERMIA; INTRINSIC LOSS POWER; MAGNETIC MANIPULATION; MAGNETIC NANOCRYSTALS; MAGNETIC TARGETING; OPTOACOUSTIC IMAGING; OPTOACOUSTIC TOMOGRAPHY;

MAGNETISM;

DOXORUBICIN; IRON; MAGNETIC IRON OXIDE NANOCRYSTAL; MAGNETIC NANOPARTICLE; NANOCARRIER; NANOCRYSTAL; UNCLASSIFIED DRUG; ANTINEOPLASTIC ANTIBIOTIC; FERRIC ION; FERRIC OXIDE; MACROGOL DERIVATIVE; NANOPARTICLE;

ADULT; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BIOCOMPATIBILITY; BREAST CANCER; CANCER CELL LINE; CELL VIABILITY; CHEMICAL STRUCTURE; COLLOID; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG STABILITY; ELECTRON SPIN RESONANCE; FEMALE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MAGNETIC FIELD; MAGNETISM; MOUSE; MULTISPECTRAL OPTOACOUSTIC TOMOGRAPHY; NANOMEDICINE; NONHUMAN; PARTICLE SIZE; PHOTOACOUSTIC TOMOGRAPHY; PRIORITY JOURNAL; SYNTHESIS; TUMOR XENOGRAFT; ANIMAL; BREAST; BREAST TUMOR; CHEMISTRY; DIAGNOSTIC IMAGING; MAGNET; NUDE MOUSE; PATHOLOGY; PHOTOACOUSTICS; PROCEDURES; X-RAY COMPUTED TOMOGRAPHY;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BREAST; BREAST NEOPLASMS; DOXORUBICIN; DRUG DELIVERY SYSTEMS; FEMALE; FERRIC COMPOUNDS; MAGNETS; MICE; MICE, NUDE; NANOPARTICLES; PHOTOACOUSTIC TECHNIQUES; POLYETHYLENE GLYCOLS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84961967640     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2016.03.015     Document Type: Article

References (78)

1. Gupta A.K., Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005, 26:3995-4021.
2. Pouponneau P., Leroux J.-C., Martel S. Magnetic nanoparticles encapsulated into biodegradable microparticles steered with an upgraded magnetic resonance imaging system for tumor chemoembolization. Biomaterials 2009, 30:6327-6332.
3. Tietze R., Lyer S., Dürr S., Struffert T., Engelhorn T., Schwarz M., et al. Efficient drug-delivery using magnetic nanoparticles - biodistribution and therapeutic effects in tumour bearing rabbits. Nanomed. Nanotechnol. Biol. Med. 2013, 9:961-971.
4. Schleich N., Po C., Jacobs D., Ucakar B., Gallez B., Danhier F., et al. Comparison of active, passive and magnetic targeting to tumors of multifunctional paclitaxel/SPIO-loaded nanoparticles for tumor imaging and therapy. J. Control. Release 2014, 194:82-91.
5. Qhattal H.S.S., Hye T., Alali A., Liu X. Hyaluronan polymer length, grafting density, and surface poly(ethylene glycol) coating influence in vivo circulation and tumor targeting of hyaluronan-grafted liposomes. ACS Nano 2014, 8:5423-5440.
6. Kunjachan S., Pola R., Gremse F., Theek B., Ehling J., Moeckel D., et al. Passive versus active tumor targeting using RGD- and NGR-modified polymeric nanomedicines. Nano Lett. 2014, 14:972-981.
7. Chen F., Cai W. Tumor vasculature targeting: a generally applicable approach for functionalized nanomaterials. Small 2014, 10:1887-1893.
8. Nacev A., Weinberg I.N., Stepanov P.Y., Kupfer S., Mair L.O., Urdaneta M.G., et al. Dynamic inversion enables external magnets to concentrate ferromagnetic rods to a central target. Nano Lett. 2014, 15:359-364.
9. Pouponneau P., Leroux J.-C., Soulez G., Gaboury L., Martel S. Co-encapsulation of magnetic nanoparticles and doxorubicin into biodegradable microcarriers for deep tissue targeting by vascular MRI navigation. Biomaterials 2011, 32:3481-3486.
10. Dames P., Gleich B., Flemmer A., Hajek K., Seidl N., Wiekhorst F., et al. Targeted delivery of magnetic aerosol droplets to the lung. Nat. Nanotechnol. 2007, 2:495-499.
11. Rudge S.R., Kurtz T.L., Vessely C.R., Catterall L.G., Williamson D.L. Preparation, characterization, and performance of magnetic iron-carbon composite microparticles for chemotherapy. Biomaterials 2000, 21:1411-1420.
12. Zoppellaro G., Kolokithas-Ntoukas A., Polakova K., Tucek J., Zboril R., Loudos G., et al. Theranostics of epitaxially condensed colloidal nanocrystal clusters, through a soft biomineralization route. Chem. Mater. 2014, 26:2062-2074.
13. 4 particles with oriented attachment structure and magnetic property. J. Phys. Chem. C 2007, 111:5281-5285.
14. Luo B., Xu S., Luo A., Wang W.-R., Wang S.-L., Guo J., et al. Mesoporous biocompatible and acid-degradable magnetic colloidal nanocrystal clusters with sustainable stability and high hydrophobic drug loading capacity. ACS Nano 2011, 5:1428-1435.
15. Lu Z., Yin Y. Colloidal nanoparticle clusters: functional materials by design. Chem. Soc. Rev. 2012, 41:6874-6887.
16. Li D., Zhang Y.-T., Yu M., Guo J., Chaudhary D., Wang C.-C. Cancer therapy and fluorescence imaging using the active release of doxorubicin from MSPs/Ni-LDH folate targeting nanoparticles. Biomaterials 2013, 34:7913-7922.
17. Pöselt E., Kloust H., Tromsdorf U., Janschel M., Hahn C., Maßlo C., et al. Relaxivity Optimization of a PEGylated iron-oxide-based negative magnetic resonance contrast agent for T2-weighted spin-echo imaging. ACS Nano 2012, 6:1619-1624.
18. Yoon T.-J., Lee H., Shao H., Hilderbrand S.A., Weissleder R. Multicore assemblies potentiate magnetic properties of biomagnetic nanoparticles. Adv. Mater. 2011, 23:4793-4797.
19. Kostopoulou A., Velu S.K.P., Thangavel K., Orsini F., Brintakis K., Psycharakis S., et al. Colloidal assemblies of oriented maghemite nanocrystals and their NMR relaxometric properties. Dalton Trans. 2014, 43:8395-8404.
20. Rebolledo A.F., Laurent S., Calero M., Villanueva A., Knobel M., Marco J.F., et al. Iron oxide nanosized clusters embedded in porous nanorods: a new colloidal design to enhance capabilities of MRI contrast agents. ACS Nano 2010, 4:2095-2103.
21. Lartigue L., Hugounenq P., Alloyeau D., Clarke S.P., Lévy M., Bacri J.-C., et al. Cooperative organization in iron oxide multi-core nanoparticles potentiates their efficiency as heating mediators and MRI contrast agents. ACS Nano 2012, 6:10935-10949.
22. Kostopoulou A., Lappas A. Colloidal magnetic nanocrystal clusters: variable length-scale interaction mechanisms, synergetic functionalities and technological advantages. Nanotechnol. Rev. 2015, 4:595-624.
23. Guo J., Yang W., Wang C. Magnetic colloidal supraparticles: design, fabrication and biomedical applications. Adv. Mater. 2013, 25:5196-5214.
24. Park J., Yu M.K., Jeong Y.Y., Kim J.W., Lee K., Phan V.N., et al. Antibiofouling amphiphilic polymer-coated superparamagnetic iron oxide nanoparticles: synthesis, characterization, and use in cancer imaging in vivo. J. Mater. Chem. 2009, 19:6412.
25. Kim J., Lee J.E., Lee S.H., Yu J.H., Lee J.H., Park T.G., et al. Designed fabrication of a multifunctional polymer nanomedical platform for simultaneous cancer-targeted imaging and magnetically guided drug delivery. Adv. Mater. 2008, 20:478-483.
26. Nasongkla N., Bey E., Ren J., Ai H., Khemtong C., Guthi J.S., et al. Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. Nano Lett. 2006, 6:2427-2430.
27. Bakandritsos A., Mattheolabakis G., Zboril R., Bouropoulos N., Tucek J., Fatouros D.G., et al. Preparation, stability and cytocompatibility of magnetic/PLA-PEG hybrids. Nanoscale 2010, 2:564-572.
28. Wang C., Xu H., Liang C., Liu Y., Li Z., Yang G., et al. Iron oxide @ polypyrrole nanoparticles as a multifunctional drug carrier for remotely controlled cancer therapy with synergistic antitumor effect. ACS Nano 2013, 7:6782-6795.
29. Hu F., MacRenaris K.W., Waters E.A., Schultz-Sikma E.A., Eckermann A.L., Meade T.J. Highly dispersible, superparamagnetic magnetite nanoflowers for magnetic resonance imaging. Chem. Commun. 2010, 46:73.
30. Sandiford L., Phinikaridou A., Protti A., Meszaros L.K., Cui X., Yan Y., et al. Bisphosphonate-anchored PEGylation and radiolabeling of superparamagnetic iron oxide: long-circulating nanoparticles for in vivo multimodal (T1 MRI-SPECT) imaging. ACS Nano 2013, 7:500-512.
31. Qi L., Sehgal A., Castaing J.-C., Chapel J.-P., Fresnais J., Berret J.-F., et al. Redispersible hybrid nanopowders: cerium oxide nanoparticle complexes with phosphonated-PEG oligomers. ACS Nano 2008, 2:879-888.
32. Gillich T., Acikgöz C., Isa L., Schlüter A.D., Spencer N.D., Textor M. PEG-stabilized core-shell nanoparticles: impact of linear versus dendritic polymer shell architecture on colloidal properties and the reversibility of temperature-induced aggregation. ACS Nano 2013, 7:316-329.
33. Amstad E., Gillich T., Bilecka I., Textor M., Reimhult E. Ultrastable iron oxide nanoparticle colloidal suspensions using dispersants with catechol-derived anchor groups. Nano Lett. 2009, 9:4042-4048.
34. Na H.B., Palui G., Rosenberg J.T., Ji X., Grant S.C., Mattoussi H. Multidentate catechol-based polyethylene glycol oligomers provide enhanced stability and biocompatibility to iron oxide nanoparticles. ACS Nano 2011, 6:389-399.
35. Yang L., Alexandridis P. Physicochemical aspects of drug delivery and release from polymer-based colloids. Curr. Opin. Colloid Interface Sci. 2000, 5:132-143.
36. Ntziachristos V., Razansky D. Molecular imaging by means of multispectral optoacoustic tomography (MSOT). Chem. Rev. 2010, 110:2783-2794.
37. Ntziachristos V. Going deeper than microscopy: the optical imaging frontier in biology. Nat. Methods 2010, 7:603-614.
38. Bao C., Beziere N., del Pino P., Pelaz B., Estrada G., Tian F., et al. Gold nanoprisms as optoacoustic signal nanoamplifiers for in vivo bioimaging of gastrointestinal cancers. Small 2013, 9:68-74.
39. Lozano N., Al-Jamal W.T., Taruttis A., Beziere N., Burton N.C., Van den Bossche J., et al. Liposome-gold Nanorod hybrids for high-resolution visualization deep in tissues. J. Am. Chem. Soc. 2012, 134:13256-13258.
40. Shen H., Jawaid A.M., Snee P.T. Poly(ethylene glycol) carbodiimide coupling reagents for the biological and chemical functionalization of water-soluble nanoparticles. ACS Nano 2009, 3:915-923.
41. Hak S., Helgesen E., Hektoen H.H., Huuse E.M., Jarzyna P.A., Mulder W.J.M., et al. The effect of nanoparticle polyethylene glycol surface density on ligand-directed tumor targeting studied in vivo by dual modality imaging. ACS Nano 2012, 6:5648-5658.
42. Xia X., Yang M., Wang Y., Zheng Y., Li Q., Chen J., et al. Quantifying the coverage density of poly(ethylene glycol) chains on the surface of gold nanostructures. ACS Nano 2012, 6:512-522.
43. Walkey C.D., Olsen J.B., Guo H., Emili A., Chan W.C.W. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J. Am. Chem. Soc. 2012, 134:2139-2147.
44. Fang C., Bhattarai N., Sun C., Zhang M. Functionalized nanoparticles with long-term stability in biological media. Small 2009, 5:1637-1641.
45. Pombo García K., Zarschler K., Barbaro L., Barreto J.A., O'Malley W., Spiccia L., et al. Zwitterionic-coated "stealth" nanoparticles for biomedical applications: recent advances in countering biomolecular corona formation and uptake by the mononuclear phagocyte system. Small 2014, 10:2516-2529.
46. Honda S., Yamamoto T., Tezuka Y. Tuneable enhancement of the salt and thermal stability of polymeric micelles by cyclized amphiphiles. Nat. Commun. 2013, 4:1574.
47. Cao P., Tong L., Hou Y., Zhao G., Guerin G., Winnik M.A., et al. Improving lanthanide nanocrystal colloidal stability in competitive aqueous buffer solutions using multivalent PEG-phosphonate ligands. Langmuir 2012, 28:12861-12870.
48. Ling D., Park W., Park Y.I., Lee N., Li F., Song C., et al. Multiple-interaction ligands inspired by mussel adhesive protein: synthesis of highly stable and biocompatible nanoparticles. Angew. Chem. Int. Ed. 2011, 50:11360-11365.
49. Torrisi V., Graillot A., Vitorazi L., Crouzet Q., Marletta G., Loubat C., et al. Preventing corona effects: multiphosphonic acid poly(ethylene glycol) copolymers for stable stealth iron oxide nanoparticles. Biomacromolecules 2014, 15:3171-3179.
50. Meng H., Xue M., Xia T., Ji Z., Tarn D.Y., Zink J.I., et al. Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model. ACS Nano 2011, 5:4131-4144.
51. Lin Y.-S., Abadeer N., Hurley K.R., Haynes C.L. Ultrastable, redispersible, small, and highly organomodified mesoporous silica nanotherapeutics. J. Am. Chem. Soc. 2011, 133:20444-20457.
52. Amstad E., Zurcher S., Mashaghi A., Wong J.Y., Textor M., Reimhult E. Surface functionalization of single superparamagnetic iron oxide nanoparticles for targeted magnetic resonance imaging. Small 2009, 5:1334-1342.
53. Gambinossi F., Chanana M., Mylon S.E., Ferri J.K. Stimulus-responsive Au@(MeO2MAx-co-OEGMAy) nanoparticles stabilized by non-DLVO interactions: implications of ionic strength and copolymer (x:y) fraction on aggregation kinetics. Langmuir 2014, 30:1748-1757.
54. Salmaso S., Caliceti P. Stealth properties to improve therapeutic efficacy of drug nanocarriers. J. Drug Deliv. 2013, 2013:e374252.
55. Unsworth L.D., Sheardown H., Brash J.L. Protein-resistant poly(ethylene oxide)-grafted surfaces: chain density-dependent multiple mechanisms of action. Langmuir 2008, 24:1924-1929.
56. Binazadeh Mojtaba, Kabiri Maryam, Unsworth Larry D. Poly(ethylene glycol) and poly(carboxy betaine) based nonfouling architectures: review and current efforts. Proteins Interfaces III State Art 2012, 621-643. American Chemical Society, (accessed 05.12.14). 10.1021/bk-2012-1120.ch028.
57. Katira P., Agarwal A., Hess H. A random Sequential adsorption model for protein adsorption to surfaces functionalized with poly(ethylene oxide). Adv. Mater. 2009, 21:1599-1604.
58. Avgoustakis K., Beletsi A., Panagi Z., Klepetsanis P., Livaniou E., Evangelatos G., et al. Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA-mPEG nanoparticles. Int. J. Pharm. 2003, 259:115-127.
59. Ohno K., Mori C., Akashi T., Yoshida S., Tago Y., Tsujii Y., et al. Fabrication of contrast agents for magnetic resonance imaging from polymer-brush-afforded iron oxide magnetic nanoparticles prepared by surface-initiated living radical polymerization. Biomacromolecules 2013, 14:3453-3462.
60. Perry J.L., Reuter K.G., Kai M.P., Herlihy K.P., Jones S.W., Luft J.C., et al. PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics. Nano Lett. 2012, 12:5304-5310.
61. Zhou J., Meng L., Feng X., Zhang X., Lu Q. One-pot synthesis of highly magnetically sensitive Nanochains coated with a highly Cross-linked and biocompatible polymer. Angew. Chem. Int. Ed. 2010, 49:8476-8479.
62. Qiu P., Jensen C., Charity N., Towner R., Mao C. Oil phase evaporation-induced self-assembly of hydrophobic nanoparticles into spherical clusters with controlled surface chemistry in an oil-in-water dispersion and comparison of behaviors of individual and clustered iron oxide nanoparticles. J. Am. Chem. Soc. 2010, 132:17724-17732.
63. Paquet C., Pagé L., Kell A., Simard B. Nanobeads highly loaded with superparamagnetic nanoparticles prepared by emulsification and seeded-emulsion polymerization. Langmuir 2010, 26:5388-5396.
64. Paquet C., de Haan H.W., Leek D.M., Lin H.-Y., Xiang B., Tian G., et al. Clusters of superparamagnetic iron oxide nanoparticles encapsulated in a hydrogel: a particle architecture generating a synergistic enhancement of the T2 relaxation. ACS Nano 2011, 5:3104-3112.
65. 4/polystyrene/silica nanospheres via combined miniemulsion/emulsion polymerization. J. Am. Chem. Soc. 2006, 128:15582-15583.
66. Bae K.H., Park M., Do M.J., Lee N., Ryu J.H., Kim G.W., et al. Chitosan oligosaccharide-stabilized ferrimagnetic iron oxide nanocubes for magnetically modulated cancer hyperthermia. ACS Nano 2012, 6:5266-5273.
67. Hugounenq P., Levy M., Alloyeau D., Lartigue L., Dubois E., Cabuil V., et al. Iron oxide monocrystalline nanoflowers for highly efficient magnetic hyperthermia. J. Phys. Chem. C 2012, 116:15702-15712.
68. Ortega D., Pankhurst Q.A. Magnetic hyperthermia. Nanoscience 2012, 60-88. Royal Society of Chemistry, Cambridge, (accessed 21.09.15). http://ebook.rsc.org/?DOI=10.1039/9781849734844-00060, P. O'Brien (Ed.).
69. Bakandritsos A., Papagiannopoulos A., Anagnostou E.N., Avgoustakis K., Zboril R., Pispas S., et al. Merging high doxorubicin loading with pronounced magnetic response and bio-repellent properties in hybrid drug nanocarriers. Small 2012, 8:2381-2393.
70. Vuong Q.L., Berret J.-F., Fresnais J., Gossuin Y., Sandre O. A universal scaling law to predict the efficiency of magnetic nanoparticles as MRI T2-contrast agents. Adv. Healthc. Mater. 2012, 1:502-512.
71. Van Roosbroeck R., Van Roy W., Stakenborg T., Trekker J., D'Hollander A., Dresselaers T., et al. Synthetic antiferromagnetic nanoparticles as potential contrast agents in MRI. ACS Nano 2014, 8:2269-2278.
72. Tromsdorf U.I., Bigall N.C., Kaul M.G., Bruns O.T., Nikolic M.S., Mollwitz B., et al. Size and surface effects on the MRI relaxivity of manganese ferrite nanoparticle contrast agents. Nano Lett. 2007, 7:2422-2427.
73. Maity D., Zoppellaro G., Sedenkova V., Tucek J., Safarova K., Polakova K., et al. Surface design of core-shell superparamagnetic iron oxide nanoparticles drives record relaxivity values in functional MRI contrast agents. Chem. Commun. 2012, 48:11398-11400.
74. Wan J., Cai W., Meng X., Liu E. Monodisperse water-soluble magnetite nanoparticles prepared by polyol process for high-performance magnetic resonance imaging. Chem. Commun. 2007, 5004-5006.
75. Razansky D., Distel M., Vinegoni C., Ma R., Perrimon N., Köster R.W., et al. Multispectral opto-acoustic tomography of deep-seated fluorescent proteins in vivo. Nat. Photonics 2009, 3:412-417.
76. Beziere N., Lozano N., Nunes A., Salichs J., Queiros D., Kostarelos K., et al. Dynamic imaging of PEGylated indocyanine green (ICG) liposomes within the tumor microenvironment using multi-spectral optoacoustic tomography (MSOT). Biomaterials 2015, 37:415-424.
77. Fu Q., Lv P., Chen Z., Ni D., Zhang L., Yue H., et al. Programmed co-delivery of paclitaxel and doxorubicin boosted by camouflaging with erythrocyte membrane. Nanoscale 2015, 7:4020-4030.
78. Tian Y., Jiang X., Chen X., Shao Z., Yang W. Doxorubicin-loaded magnetic silk fibroin nanoparticles for targeted therapy of multidrug-resistant Cancer. Adv. Mater. 2014, 26:7393-7398.